.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Fish and Richardson
Covington
Cipla
Deloitte
Fuji
Queensland Health
Express Scripts
Farmers Insurance

Generated: November 18, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: eribulin mesylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc
HALAVEN
eribulin mesylate
SOLUTION;INTRAVENOUS201532NDAEisai Inc.62856-389-011 VIAL in 1 CARTON (62856-389-01) > 2 mL in 1 VIAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Julphar
Daiichi Sankyo
Medtronic
Healthtrust
AstraZeneca
Mallinckrodt
Citi
Accenture
McKinsey

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot